PLGA nanoparticles-based delivery of SRC kinase signaling pathway inhibitor KX2-391 for the treatment of non-alcoholic steatohepatitis

D.W. Kurniawan; Garima Dhawan; D. Oosterhuis; G. Storm; P. Olinga; D.P. Mishra; J.  Prakash; Ruchi Bansal

doi:10.1177/2050640618792832

PLGA nanoparticles-based delivery of SRC kinase signaling pathway inhibitor KX2-391 for the treatment of non-alcoholic steatohepatitis

D.W. Kurniawan, Garima Dhawan, D. Oosterhuis, G. Storm, P. Olinga, D.P. Mishra, J. Prakash, Ruchi Bansal

Biomaterials Science and Technology

Research output: Contribution to conference › Poster › Academic

Original language	English
Pages	545
DOIs	https://doi.org/10.1177/2050640618792832
Publication status	Published - 2018
Event	26th United European Gastroenterology Week Vienna 2018 - Vienna, Austria Duration: 20 Oct 2018 → 24 Oct 2018 Conference number: 26 https://www.ueg.eu/week/past-future/ueg-week-2018/

Conference

Conference	26th United European Gastroenterology Week Vienna 2018
Abbreviated title	UEG Week 2018
Country/Territory	Austria
City	Vienna
Period	20/10/18 → 24/10/18
Internet address	https://www.ueg.eu/week/past-future/ueg-week-2018/

Access to Document

10.1177/2050640618792832

PLGA nanoparticles-based delivery of SRC kinase signaling pathway inhibitor KX2-391 for the treatment of non-alcoholic steatohepatitis
Kurniawan, D. W. (Recipient), Oct 2018
Prize
Young Investigator Travel award (€750,-), United European Gastroenterology week
Bansal, R. (Recipient), Oct 2018
Prize

Cite this

Kurniawan, D. W., Dhawan, G., Oosterhuis, D., Storm, G., Olinga, P., Mishra, D. P., Prakash, J., & Bansal, R. (2018). PLGA nanoparticles-based delivery of SRC kinase signaling pathway inhibitor KX2-391 for the treatment of non-alcoholic steatohepatitis. 545. Poster session presented at 26th United European Gastroenterology Week Vienna 2018, Vienna, Austria. https://doi.org/10.1177/2050640618792832

@conference{d35aed1a898c46b6b798e8e4c74273c5,

title = "PLGA nanoparticles-based delivery of SRC kinase signaling pathway inhibitor KX2-391 for the treatment of non-alcoholic steatohepatitis",

author = "D.W. Kurniawan and Garima Dhawan and D. Oosterhuis and G. Storm and P. Olinga and D.P. Mishra and J. Prakash and Ruchi Bansal",

note = "published in: UEG journal 2018, 6 (suppl. 8), 545; 26th United European Gastroenterology Week Vienna 2018, UEG Week 2018 ; Conference date: 20-10-2018 Through 24-10-2018",

year = "2018",

doi = "10.1177/2050640618792832",

language = "English",

pages = "545",

url = "https://www.ueg.eu/week/past-future/ueg-week-2018/",

}

Kurniawan, DW, Dhawan, G, Oosterhuis, D, Storm, G, Olinga, P, Mishra, DP, Prakash, J & Bansal, R 2018, 'PLGA nanoparticles-based delivery of SRC kinase signaling pathway inhibitor KX2-391 for the treatment of non-alcoholic steatohepatitis', 26th United European Gastroenterology Week Vienna 2018, Vienna, Austria, 20/10/18 - 24/10/18 pp. 545. https://doi.org/10.1177/2050640618792832

PLGA nanoparticles-based delivery of SRC kinase signaling pathway inhibitor KX2-391 for the treatment of non-alcoholic steatohepatitis. / Kurniawan, D.W.; Dhawan, Garima; Oosterhuis, D. et al.
2018. 545 Poster session presented at 26th United European Gastroenterology Week Vienna 2018, Vienna, Austria.

Research output: Contribution to conference › Poster › Academic

TY - CONF

T1 - PLGA nanoparticles-based delivery of SRC kinase signaling pathway inhibitor KX2-391 for the treatment of non-alcoholic steatohepatitis

AU - Kurniawan, D.W.

AU - Dhawan, Garima

AU - Oosterhuis, D.

AU - Storm, G.

AU - Olinga, P.

AU - Mishra, D.P.

AU - Prakash, J.

AU - Bansal, Ruchi

N1 - Conference code: 26

PY - 2018

Y1 - 2018

U2 - 10.1177/2050640618792832

DO - 10.1177/2050640618792832

M3 - Poster

SP - 545

T2 - 26th United European Gastroenterology Week Vienna 2018

Y2 - 20 October 2018 through 24 October 2018

ER -

PLGA nanoparticles-based delivery of SRC kinase signaling pathway inhibitor KX2-391 for the treatment of non-alcoholic steatohepatitis

Conference

Access to Document

Prizes

PLGA nanoparticles-based delivery of SRC kinase signaling pathway inhibitor KX2-391 for the treatment of non-alcoholic steatohepatitis

Young Investigator Travel award (€750,-), United European Gastroenterology week

Cite this